Dr. Merlini talks on AL amyloidosis as a model for treating other amyloid disorders
#ISA_2022
Light chains cardiotoxicity in many studies
The age dependent process of handling LC #ISA_2022
Tissue specific impairement
#ISA_2022
Imapirement of mitochondria plays a central role in failure of clearance of misfolded protein #ISA_2022
Age dependent LC toxicity in endothelial cells #ISA_2022
Mechanisms of increased NTproBNP /BNP increase #ISA_2022
NTproBNP as a biomarker in AL
#ISA_2022
The problematic issue of late diagnosis of AL amyloidosis #ISA_2022
AL is an a state at the intersection of MGUS and MM
#ISA_2022
Why we need fibril removers in advanced disease
#ISA_2022
CAEL 101 pIII is underway
#ISA_2022
Mice dont develop amyloidosis #ISA_2022
A trangenic mouse model was reported on #ISA_2022
The pipeline for fibril removers #ISA_2022
A model of cure
#ISA_2022
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.